Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Burger

Showing results (141-150 of 337) with videos related to

Pageof 34
Sort By:
Antiviral Therapy|September 5, 2022
Pharmacokinetic interaction between raltegravir and rifampicin in an infant with HIV exposed to active TB: a case reportMarlotte Aa van der Veer, Tom G Jacobs, Laura H Bukkems, et al.
Antiviral Therapy|September 18, 2015
Ribavirin concentration determines treatment success of first-generation DAA-based chronic HCV therapyClara Tmm de Kanter, Maria Buti, Ralph DeMasi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 14, 2009
Efavirenz dose reduction is safe in patients with high plasma concentrations and may prevent efavirenz discontinuationsMatthijs van Luin, Luuk Gras, Clemens Richter, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 24, 2014
[e-Health interventions and improvement in treatment adherence]Angelien Sieben, S J H Bas Bredie, C J H M Kees van Laarhoven, et al.
AIDS (London, England)|April 19, 2013
Is nevirapine dose-escalation appropriate in young, African, HIV-infected children?Quirine Fillekes, Veronica Mulenga, Desiré Kabamba, et al.
AIDS (London, England)|November 13, 2015
Safety of rilpivirine and boceprevir coadministration in HIV-infected patients treated for acute hepatitis C virus infectionSebastiaan J Hullegie, Brenda C M de Winter, Dirk Posthouwer, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 11, 2018
Manual punch versus automated flow-through sample desorption for dried blood spot LC-MS/MS analysis of voriconazoleLisa C Martial, Erik van den Hombergh, Cornelis Tump, et al.
The Lancet. Infectious Diseases|September 8, 2016
Rethinking the risk-benefit ratio of efavirenz in HIV-infected childrenLisa Van de Wijer, Arnt F A Schellekens, David M Burger, et al.
British Journal of Clinical Pharmacology|February 20, 2002
Long-term suppression of viral replication despite low plasma saquinavir concentrations in the CHEESE StudyRolf P G van Heeswijk, James W T Cohen Stuart, David M Burger, et al.
British Journal of Clinical Pharmacology|January 17, 2026
Pharmacokinetics of dolutegravir, tenofovir and lamivudine during venous-venous extracorporeal membrane oxygenation (VV-ECMO): A case reportTom C Zwart, Emiel Leegwater, Thomas H Ottens, et al.
Pageof 34

Showing results (141-150 of 337) with videos related to

Sort By:
Pageof 34
Antiviral Therapy|September 5, 2022
Pharmacokinetic interaction between raltegravir and rifampicin in an infant with HIV exposed to active TB: a case reportMarlotte Aa van der Veer, Tom G Jacobs, Laura H Bukkems, et al.
Antiviral Therapy|September 18, 2015
Ribavirin concentration determines treatment success of first-generation DAA-based chronic HCV therapyClara Tmm de Kanter, Maria Buti, Ralph DeMasi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 14, 2009
Efavirenz dose reduction is safe in patients with high plasma concentrations and may prevent efavirenz discontinuationsMatthijs van Luin, Luuk Gras, Clemens Richter, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 24, 2014
[e-Health interventions and improvement in treatment adherence]Angelien Sieben, S J H Bas Bredie, C J H M Kees van Laarhoven, et al.
AIDS (London, England)|April 19, 2013
Is nevirapine dose-escalation appropriate in young, African, HIV-infected children?Quirine Fillekes, Veronica Mulenga, Desiré Kabamba, et al.
AIDS (London, England)|November 13, 2015
Safety of rilpivirine and boceprevir coadministration in HIV-infected patients treated for acute hepatitis C virus infectionSebastiaan J Hullegie, Brenda C M de Winter, Dirk Posthouwer, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 11, 2018
Manual punch versus automated flow-through sample desorption for dried blood spot LC-MS/MS analysis of voriconazoleLisa C Martial, Erik van den Hombergh, Cornelis Tump, et al.
The Lancet. Infectious Diseases|September 8, 2016
Rethinking the risk-benefit ratio of efavirenz in HIV-infected childrenLisa Van de Wijer, Arnt F A Schellekens, David M Burger, et al.
British Journal of Clinical Pharmacology|February 20, 2002
Long-term suppression of viral replication despite low plasma saquinavir concentrations in the CHEESE StudyRolf P G van Heeswijk, James W T Cohen Stuart, David M Burger, et al.
British Journal of Clinical Pharmacology|January 17, 2026
Pharmacokinetics of dolutegravir, tenofovir and lamivudine during venous-venous extracorporeal membrane oxygenation (VV-ECMO): A case reportTom C Zwart, Emiel Leegwater, Thomas H Ottens, et al.
Pageof 34